Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system

Abstract

ObjectiveTo explore the safety of ultrasound and microbubbles for enhancing the chemotherapeutic sensitivity of malignant tumors in the digestive system in a clinical trial, as well as its efficacy.MethodsFrom October 2014 to June 2016, twelve patients volunteered to participate in this study. Eleven patients had hepatic metastases from tumors of the digestive system, and one patient had pancreatic carcinoma. According to the mechanical index (MI) in the ultrasound field, patients were classified into four groups with MIs of 0.4, 0.6, 0.8 and 1.0. Within half an hour after chemotherapy, patients underwent ultrasound scanning with ultrasound microbubbles (SonoVue) to enhance the efficacy of chemotherapy. All adverse reactions were recorded and were classified in 4 grades according to the Common Terminology Criteria for Adverse Events version 4.03 (CTCAE V4.03). Tumor responses were evaluated by the Response Evaluation Criteria in Solid Tumors version 1.1 criteria. All the patients were followed up until progression.ResultsAll the adverse reactions recorded were level 1 or level 2. No local pain occurred in any of the patients. Among all the adverse reactions, fever might be related to the treatment with ultrasound combined with microbubbles. Six patients had stable disease (SD), and one patient had a partial response (PR) after the first cycle of treatment. At the end of follow-up, tumor progression was restricted to the original sites, and no new lesions had appeared.ConclusionsOur preliminary data showed the potential role of a combined treatment with ultrasound and microbubbles in enhancing the chemotherapeutic sensitivity of malignant tumors of the digestive system. This technique is safe when the MI is no greater than 1.0.

Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery

“…Hepatic metastases from the digestive system. A tolerability study of chemotherapeutic delivery using microbubble-assisted ultrasound for the treatment of liver metastases from gastrointestinal tumors and pancreatic carcinoma was conducted at Beijing Cancer Hospital, China (Wang et al 2018). Thirty minutes after intravenous infusion of chemotherapy (for both monotherapy and combination therapy), 1 mL of SonoVue microbubbles was intravenously administered and was repeated another five times in 20 min.…”

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer

“…PC is desmoplastic with highly mesenchymal-like substrates, which favours hypoxia, induces epithelial-to-mesenchymal transition (EMT) and results in tumor cell metastasis ( 7 ). PCs are surrounded by a dense fibrotic stroma containing dense masses, pancreatic stellate cells (PSCs) and an extracellular matrix.…”

Recent Advances in Microbubble-Augmented Cancer Therapy

“…A later clinical trial was conducted to test the tolerability of UTMD with chemotherapy [62]. The study enrolled 12 patients including 11 with hepatic metastatic tumors and one with a pancreatic tumor.…”